| Announce Date | 12/19/2025 |
| EPS Normalized Actual | $1.26 (Beat by $0.03) |
| EPS GAAP Actual | $1.26 (Beat by $0.03) |
| Revenue Actual | $1.5576B |
| Revenue Surprise | Beat by $1557.6M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| May 2028 | 0 | INF | 0 | 0 | 3 |
| May 2027 | 5.81 | 16.88 | 5.77718 | 5.89122 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.1 | 1.1 | 1.5576B | 15.45% | 1557.6M |
| FQ3 2025 (Aug 2025) | 1.07 | 1.07 | 1.54B | 14.38% | 1540M |
| FQ2 2025 (May 2025) | 0.82 | 0.82 | 1.4273B | 9.26% | 1427.3M |
| FQ1 2025 (Feb 2025) | 1.44 | 1.44 | 1.509B | 4.62% | 1509M |
| FQ4 2024 (Nov 2024) | -1.19 | -1.19 | 1.3169B | 4.48% | 1316.9M |
| FQ3 2024 (Aug 2024) | 1.19 | 1.19 | 1.3185B | 2.46% | 1318.5M |
| FQ2 2024 (May 2024) | 1.06 | 1.06 | 1.2951B | 5.06% | 1295.1M |
| FQ1 2024 (Feb 2024) | 1.39 | 1.39 | 1.4393B | 4.05% | 1439.3M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 1.59209 | -- | 1.57013 | 1.62256 | 5 |
| FQ1 2028 (Feb 2028) | 1.78279 | -- | 1.77083 | 1.82366 | 8 |
| FQ4 2027 (Nov 2027) | 1.42618 | -- | 1.41661 | 1.45888 | 8 |
| FQ3 2027 (Aug 2027) | 1.43575 | -- | 1.41594 | 1.46322 | 4 |
| FQ2 2027 (May 2027) | 1.4032 | -- | 1.37696 | 1.49848 | 6 |
| FQ1 2027 (Feb 2027) | 1.69338 | -- | 1.66172 | 1.80837 | 6 |
| FQ4 2026 (Nov 2026) | 1.30529 | 15.73 | 1.28088 | 1.39392 | 11 |
| FQ3 2026 (Aug 2026) | 1.29988 | 17.68 | 1.29593 | 1.30791 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 1.82B | -- | 1.8B | 1.85B | 3 |
| FQ1 2028 (Feb 2028) | 2.02B | -- | 2.01B | 2.05B | 8 |
| FQ4 2027 (Nov 2027) | 1.77B | -- | 1.76B | 1.8B | 5 |
| FQ3 2027 (Aug 2027) | 1.74B | -- | 1.72B | 1.77B | 6 |
| FQ2 2027 (May 2027) | 1.52B | -- | 1.49B | 1.6B | 5 |
| FQ1 2027 (Feb 2027) | 1.68B | -- | 1.66B | 1.77B | 10 |
| FQ4 2026 (Nov 2026) | 1.53B | -2.08 | 1.5B | 1.61B | 7 |
| FQ3 2026 (Aug 2026) | 1.48B | -3.95 | 1.48B | 1.49B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.1 | 1.1 | 100% | |
| FQ3 2025 (Aug 2025) | 1.07 | 1.07 | 100% | |
| FQ2 2025 (May 2025) | 0.82 | 0.82 | 100% | |
| FQ1 2025 (Feb 2025) | 1.44 | 1.44 | 100% | |
| FQ4 2024 (Nov 2024) | -1.19 | -1.19 | 100% | |
| FQ3 2024 (Aug 2024) | 1.19 | 1.19 | 100% | |
| FQ2 2024 (May 2024) | 1.06 | 1.06 | 100% | |
| FQ1 2024 (Feb 2024) | 1.39 | 1.39 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $1.56B | $1557.6M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $1.54B | $1540M | 100% |
| FQ2 2025 (May 2025) | $0B | $1.43B | $1427.3M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $1.51B | $1509M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $1.32B | $1316.9M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $1.32B | $1318.5M | 100% |
| FQ2 2024 (May 2024) | $0B | $1.3B | $1295.1M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $1.44B | $1439.3M | 100% |